SSA
CVRS

Schonfeld Strategic Advisors’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,494,700
Closed -$7.43M – 1355
2019
Q2 		$7.43M Buy
2,494,700
+694,700
+39% +$1.74M 0.26% 93
2019
Q1 		$3.13M Buy
1,800,000
+200,000
+13% +$276K 0.11% 251
2018
Q4 		$1.34M Buy
1,600,000
+600,000
+60% +$715K 0.05% 404
2018
Q3 		$1.42M Buy
1,000,000
+200,000
+25% +$219K 0.06% 360
2018
Q2 		$661K Buy
+800,000
New +$772K 0.04% 483

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Schonfeld Strategic Advisors's CVRS Position: Q3 2019 in Review

Schonfeld Strategic Advisors sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2019, closing a stake of 2,494,700 shares — an estimated $7.43M sold.

Schonfeld Strategic Advisors first reported a position in CVRS in Q2 2018 and held it in 5 quarters. The position peaked at $7.43M in Q2 2019. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

  • Schonfeld Strategic Advisors reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2019 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 2,494,700 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2019, an estimated $7.43M.
  • Schonfeld Strategic Advisors first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2018 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's CORINDUS VASCULAR ROBOTICS, INC position peaked at $7.43M in Q2 2019.
  • 101 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.